Antibiotic use and the prevalence of antibiotic resistance in bacteria from healthy volunteers in the dutch community

Infection

Volumn 31, Issue 1, 2003, Pages 9-14

  Bruinsma, N ^a   Stobberingh, E ^a   De Smet, P ^b   Van Den Bogaard, A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Institute of Pharmaceutical Data   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AVOPARCIN; CEFAZOLIN; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; OXYTETRACYCLINE; TRIMETHOPRIM; TYLOSIN; VANCOMYCIN; VIRGINIAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DRUG USE; ENTEROCOCCUS; ESCHERICHIA COLI; FECES CULTURE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NONHUMAN; NORMAL HUMAN;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; ESCHERICHIA COLI; FECES; HUMANS; MICROBIAL SENSITIVITY TESTS; NETHERLANDS;

EID: 0037263491     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-3035-8     Document Type: Article

References (35)

1. Levy SB: Factors impacting on the problems of antibiotic resistance. J Antimicrob Chemother 2002; 49: 25-30.
2. Sørensen TL, Monnet D: Control of antibiotic use in the community: the Danish experience. Infect Control Hosp Epidemiol 2000; 21: 387-389.
3. Reservoirs of Antibiotic Resistance Network (ROAR) report: Commensal bacteria - an important reservoir of antibiotic resistance genes? A position paper from the Working Group on Antibiotic Resistance in Commensal Bacteria, September 1998.
4. Van den Bogaard AE, Stobberingh EE: Antibiotic use in animals: impact on bacterial resistance and public health. Drugs 1999; 58: 589-607.
5. Mellon N, Benbrook C, Ben brook KL: Hogging it: estimates of antimicrobial abuse in livestock. Union of Concerned Scientists, January 2001.
6. Klare I, Heier H, Claus H, Bohme G, Marin S, Seltmann, G, Hakenbeck R, Antanassova V, Witte W: Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist 1995; 1: 265-272.
7. Willems RJ, Top J, van den Braak N, van Belkum A, Endtz H, Mevius D, Stobberingh E, van den Bogaard A, van Embden JD: Host specifity of vancomycin-resistant Enterococcus faecium. J Infect Dis 2000; 182: 816-823.
8. Van den Bogaard AE, London N, Stobberingh EE: Antimicrobial resistance in pig faecal samples from The Netherlands (five abattoirs) and Sweden. J Antimicrob Chemother 2000; 45: 663-671.
9. Österblad M, Hakanen A, Manninen R, Leistevuo T, Peltonen R, Meurman O, Huovinen P, Kotilainen P: A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother 2000; 44: 1479-1484.
10. Shanahan PMA, Thomson J, Amyes SGB: β-Lactam resistance in normal faecal flora from South Africa. Epidemiol Infect 1995; 115: 243-253.
11. Levy SB, Marschall B, Schleuderberg S, Rowse D, Davies J: High frequency of antimicrobial resistance in human fecal flora. Antimicrob Agents Chemother 1988; 32: 1801-1806.
12. Van den Bogaard AE, Stobberingh EE: Vancomycin resistant enterococci in turkeys and farmers. N Engl J Med 1997; 337: 1558-1559.
13. Vatopoulos AC, Varvaresou E, Petridou E, Moustaki M, Kyiakopoulos M, Kapogiannis D, Sarafoglou S, Fretzagias A, Kalapothaki V: High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece. Clin Microbiol Infect 1998; 4: 563-569.
14. Lester SC, Pilar Pla del M, Wang F, Prez Schael I, Jiang H, O'Brien TF: The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and Qin Pu, China. N Engl J Med 1990; 323: 285-289.
15. Van de Mortel HJE, Jansen EJP, Dinant GJ, London N, Palacios Prü E, Stobberingh EE: The prevalence of antibiotic-resistant faecal Escherichia coli in healthy volunteers in Venezuela. Infection 1998; 26: 292-297.
16. London N, Nijsten R, van den Bogaard A, Stobberingh E: Carriage of antibiotic-resistant Escherichia coli by healthy volunteers during a 15-week period. Infection 1994; 22: 187-192.
17. London N, Nijsten R, Van den Bogaard A, Stobberingh E: Antibiotic resistance of faecal Enterobacteriaceae isolated from healthy volunteers, a 15-week follow-up study. J Antimicrob Chemother 1993; 32: 83-91.
18. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing: eight informational supplement. NCCLS, 940 West Valley Road, Pensylvania, 1998, USA.
19. Nijsten R, London N, Van den Bogaard A, Stobberingh E: Resistance in faecal Escherichia coli isolated from pig farmers and abattoir workers. Epidemiol Infect 1994; 113: 45-52.
20. Bonten M, Stobberingh E, Philips J, Houben A: High prevalence of antibiotic resistant Escherichia coli in faecal samples of students in the south-east of The Netherlands. J Antimicrob Chemother 1990; 26: 585-592.
21. Van den Bogaard AE, Bruinsma N, Stobberingh EE: The effect of banning avoparcin on VRE carriage in The Netherlands. J Antimicrob Chemother 2000; 46: 145-153.
22. De Neeling AJ: Antibioticagebruik en het optreden van resistentie. In: Volksgezondheid Toekomst Verkenning. Elsevier/De Tijdstroom, Maarssen 1997, pp 793-800.
23. Goettsch W, van Pelt W, Nagelkerke N, Hendrix MGR, Buiting AGM, Petit PL, Sabbe LJ, van Griethuysen AJ, de Neeling AJ: Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000; 46: 223-228.
24. Garau J, Xercavins M, Rodriguez-Carballeira M, Gomez-Vera JR, Coll I, Vidal D, Llovet T, Ruiz-Bremon A: Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 1999; 43: 2736-2741.
25. Guyot A, Threlfall EJ, Hampton MD, Cheasty TJ: Molecular epidemiology of multi-resistant Escherichia coli. J Hosp Infect 1999; 43: 39-48.
26. Kahlmeter G: The ECO.SENS project: a prospective, multinational, multicentre epidemiologcal survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens - interim report. J Antimicrob Chemother 2000;46 (suppl 1):15-22.
27. Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999; 282: 325-326.
28. Vromen M, van der Ven AJ, Knols A, Stobberingh EE: Antimicrobial resistance patterns in urinary isolates from nursing home residents. Fifteen years of data reviewed. J Antimicrob Chemother 1999; 44: 113-116.
29. Zhanel GG, Karlowsky JA, Harding GK, Carrie A, Mazzulli T, Low DE, Hoban DJ: A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother 2000; 44: 1089-1092.
30. Valdivieso F, Trucco O, Prado V, Diaz MC, Ojeda A: Antimicrobial resistance of agents causing urinary tract infections in 11 Chilean hospitals. PRONARES project. Rev Med Chil 1999; 127: 1033-1040.
31. Chomarat M: Resistance of bacteria in urinary tract infections. Internat J Antimicrob Agents 2000; 16: 483-487.
32. McOsker CC, Fitzpatrick PM: Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother 1994; 33 (suppl A): 23-30.
33. Wiersma TJ, Timmermans AE:Summary of the 'Urinary tract infections'guideline (first revision) of the Dutch College of General Practitioners [article in Dutch]. Ned Tijschr Geneesk 2001; 145: 720-726.
34. Pechere JC: Streptogramins; a unique class of antibiotics. Drugs 1996; 51 (suppl 1):13-19.
35. Klare I, Badstübner D, Konstabel C, Böhme G, Claus H, Witte W: Decreased incidence of vanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb Drug Resist 1999; 5: 45-52.